Visually

A matter of time

Annapurani V | Updated on November 17, 2020

The race to develop a Covid-19 vaccine is getting heated. Yesterday, Moderna announced that its RNA-based vaccine was 94.5 per cent effective in preventing the virus. Last week, Pfizer and BioNTech announced that their Covid vaccine was more than 90 per cent effective in the first results of the Phase 3 study. Here's a look at their trial progress, estimated capacities of vaccine manufacturers and more


 

 


 


 


 

 

Published on November 16, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor